Probiotics for Constipation in Parkinson Disease A Randomized Placebo-Controlled Study

被引:136
|
作者
Tan, Ai Huey [1 ,2 ,3 ]
Lim, Shen-Yang [1 ,2 ,3 ]
Chong, Kah Kian [1 ,2 ,3 ]
Manap, Mohammad Addin Azhan A. [1 ,2 ,3 ]
Hor, Jia Wei [1 ,2 ,3 ]
Lim, Jia Lun [1 ,2 ,3 ]
Low, Soon Chai [1 ,2 ,3 ]
Chong, Chun Wie [4 ]
Mahadeva, Sanjiv [5 ]
Lang, Anthony E. [6 ,7 ]
机构
[1] Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia
[3] Univ Malaya, Fac Med, Mah Pooi Soo & Tan Chin Nam Ctr Parkinsons & Rela, Kuala Lumpur, Malaysia
[4] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Selangor, Malaysia
[5] Univ Malaya, Fac Med, Dept Med, Div Gastroenterol, Kuala Lumpur, Malaysia
[6] Toronto Western Hosp, Safra Program Parkinsons Dis, Toronto, ON, Canada
[7] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada
关键词
CONTROLLED-TRIAL; SYMPTOMS; INFLAMMATION; ENTEROCOCCUS; MICROBIOME; PREBIOTICS; LEVODOPA; MARKERS; SAFETY;
D O I
10.1212/WNL.0000000000010998
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To determine whether probiotics are effective for constipation, a common and often difficultto-treat problem, in Parkinson disease (PD). Methods In this double-blind, randomized, placebo-controlled, single-center trial, 280 patients with PD were screened, and 72 eligible patients were block-randomized (1:1) to receive either multistrain probiotics capsules (n = 34) or identical-appearing placebo (n = 38), for 4 weeks. The primary endpoint was the change in the average number of spontaneous bowel movements (SBM) per week during the last 2 weeks of intervention compared with the 2-week preintervention phase, recorded by daily stool diary. Secondary outcome measures included changes in stool consistency, constipation severity score, and quality of life related to constipation. Satisfaction with intervention received was assessed. Change in levels of fecal calprotectin, a marker of intestinal inflammation, was an exploratory outcome. Results SBM increased by 1.0 +/- 1.2 per week after treatment with probiotics and decreased by 0.3 +/- 1.0 per week in the placebo group (mean difference 1.3, 95% confidence interval 0.8-1.8, p < 0.001). Significant improvements were also seen for secondary outcomes after correction for multiple comparisons, including stool consistency (p = 0.009) and quality of life related to constipation (p = 0.001). In the treatment group, 65.6% reported satisfaction with the intervention vs only 21.6% in the placebo group (p < 0.001). One patient (2.9%) in the treatment group withdrew due to a nonserious adverse event. Fecal calprotectin did not change significantly during the study. Conclusions Multistrain probiotics treatment was effective for constipation in PD. Further studies are needed to investigate the long-term efficacy and safety of probiotics in PD, as well as their mechanisms of action. Classification of Evidence This study provides Class I evidence that, for people with PD, multistrain probiotics significantly increased the average number of SBM per week.
引用
收藏
页码:E772 / E782
页数:11
相关论文
共 50 条
  • [11] Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled Study
    Eggert, Karla
    Squillacote, David
    Barone, Paolo
    Dodel, Richard
    Katzenschlager, Regina
    Emre, Murat
    Lees, Andrew J.
    Rascol, Olivier
    Poewe, Werner
    Tolosa, Eduardo
    Trenkwalder, Claudia
    Onofrj, Marco
    Stocchi, Fabrizio
    Nappi, Giuseppe
    Kostic, Vladimir
    Potic, Jagoda
    Ruzicka, Evzen
    Oertel, Wolfgang
    MOVEMENT DISORDERS, 2010, 25 (07) : 896 - 905
  • [12] Effect of probiotics on MDS UPDRS in Parkinson disease at 12 weeks: A Randomized double-blind placebo-controlled trial
    George, G.
    Iype, T.
    MOVEMENT DISORDERS, 2021, 36 : S174 - S174
  • [13] Randomized Placebo-controlled Trial of Memantine for Dementia in Parkinson's Disease
    Marsh, Laura
    Biglan, Kevin M.
    Williams, James R.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (03): : S78 - S79
  • [14] Randomized placebo-controlled trial of zonisamide in patients with Parkinson's disease
    Murata, Miho
    Hasegawa, Kazuko
    Kanazawa, Ichiro
    Shirakura, Kenji
    Kochi, Kenji
    Shimazu, Rieko
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2016, 4 (01): : 10 - 15
  • [15] Creatine supplementation in Parkinson disease:: A placebo-controlled randomized pilot trial
    Bender, A.
    Koch, W.
    Elstner, M.
    Schombacher, Y.
    Bender, J.
    Moeschl, M.
    Gekeler, F.
    Mueller-Myhsok, B.
    Gasser, T.
    Tatsch, K.
    Klopstock, T.
    NEUROLOGY, 2006, 67 (07) : 1262 - 1264
  • [16] Randomized placebo-controlled trial of memantine for dementia in Parkinson's disease
    Marsh, L.
    Biglan, K.
    Williams, J. R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S82 - S82
  • [17] Helicobacter pyloriEradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial
    Tan, Ai Huey
    Lim, Shen-Yang
    Mahadeva, Sanjiv
    Loke, Mun Fai
    Tan, Jiun Yan
    Ang, Ban Hong
    Chin, Kok Ping
    Mohammad Adnan, Amni Fatihah
    Ong, Shawna Mei Chien
    Ibrahim, Aimi Izzah
    Zulkifli, Nusyaibah
    Lee, Jing Kun
    Lim, Wan Ting
    Teo, Yong Teck
    Kok, Yong Leng
    Ng, Tze Ying
    Tan, Aaron Guan Siang
    Zulkifle, Intan Maisara
    Ng, Chin Khoon
    Ee, Soon Sean
    Arafin, Shuhaina
    Mohamad Shukori, Khairunnisa
    Vadivelu, Jamunarani S.
    Marras, Connie
    Fox, Susan H.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2020, 35 (12) : 2250 - 2260
  • [18] Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study
    Vleggaar, Frank R.
    Monkelbaan, Jan F.
    van Erpecurn, Karel J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : 688 - 692
  • [19] Probiotics in addition to antibiotics for the treatment of acute tonsillitis: a randomized, placebo-controlled study
    Gilbey, P.
    Livshits, L.
    Sharabi-Nov, A.
    Avraham, Y.
    Miron, D.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (05) : 1011 - 1015
  • [20] Probiotics in addition to antibiotics for the treatment of acute tonsillitis: a randomized, placebo-controlled study
    P. Gilbey
    L. Livshits
    A. Sharabi-Nov
    Y. Avraham
    D. Miron
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 1011 - 1015